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Hematopoietic stem cells (HSCs) form a rare population of multipotent stem cells, which give rise to all hemato-
poietic lineages. HSCs home to bone marrow niches and circulate between blood and bone marrow. Many fac-
tors, especially SDF1a, affect the circulation of HSCs, but these have not been fully recognized. SDF1a has been 
shown to bind CXCR7 in addition to CXCR4 and can also function as SDF1a/CXCR4 modulator. CXCR7 plays 
a role in HSCs homing via SDF1a gradient and is a mediator of CXCR4/SDF1a axis. This review describes the 
current concepts and questions concerning CXCR7/CXCR4/SDF1a axis as an important key in hematopoietic 
stem cells homing with particular emphasis on CXCR7 receptor. Homing of HSCs is an essential step for suc-
cessful hematopoietic stem cell transplantation. 
 






Hematopoietic stem cells migrate 
through blood circulation and bone marrow 
niches. HSCs migration to bone marrow is 
an essential step in clinical stem cell en-
graftment. HSCs are a rare population of 
multipotent stem cells lodging in a special-
ized microenvironment within the bone mar-
row known as bone marrow niche. Homing 
of HSCs starts from the embryonic period, 
when HSCs migrate from the fetal liver to 
seed bone marrow via crosstalk between cy-
tokines and adhesion molecules, especially 
SDF1a, CXCR4 and CXCR7 pathways 
(McGrath et al., 1999; Gazitt, 2004). SDF1a 
chemokine and its receptors have been im-
plicated in survival, proliferation and traf-
ficking of CD34+ cells (Lataillade et al., 
2000; Aiuti et al., 1997; Mohle et al., 1998; 
Wright et al., 2002). CXCR4 was deemed to 
be the sole receptor for SDF1a but CXCR7 
was later found to be another high affinity 
receptor for SDF1a (Balabanian et al., 2005; 
Burns et al., 2006). It is unclear whether the 
SDF1a/CXCR7 axis regulates HSCs homing, 
but there are evidences that CXCR7 modu-
lates CXCR4/SDF1 responses (Hartmann et 
al., 2008; Naumann et al., 2010; Uto-
Konomi et al., 2013). 
 
BONE MARROW NICHES AND  
HOMING OF HSCS 
HSCs are multipotent stem cells capable 
of generating all hematopoietic lineages. The 
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bone marrow cavities are the main residence 
for post-natal human hematopoiesis. HSCs 
must be maintained in a specific niche, 
which is critical for HSCs fate and hemato-
poiesis. HSCs niche, which is an inductive 
microenvironment, provides factors that 
maintain the hematopoietic stem cells and 
prevent their differentiation (Schofield, 
1978). Bone marrow niche maintains several 
functions of HSCs, including stem cell adhe-
sion, self-renewal (Jones and Wagers, 2008), 
apoptosis (Lin, 2002) as well as homing and 
mobilization. HSCs physiologically leave the 
bone marrow and migrate between blood cir-
culation and bone marrow niche (Wright et 
al., 2001), a process termed mobilization and 
homing. Many agents have been reported to 
affect the homing of HSCs, most notably in-
tegrins (Watanabe et al., 1998; Qian et al., 
2006), selectins (Sullivan et al., 2011) and 
chemokines (Aiuti et al., 1997). CXCR7/ 
CXCR4/SDF1a axis plays major roles in 
stem cell motility, which will be discussed 
later. 
 
SDF1 alpha/CXCR4 axis 
SDF1a is expressed in bone tissue and 
endothelial cells and can induce the expres-
sion of LFA1 and VLA4 adhesion mole-
cules. However, the expression of CXCR4 in 
USSCs is decreased with the increase in pas-
sage number. There are two isoforms of 
SDF1a, and its gene is located on human 
chromosome 10 (Levesque et al., 2003; 
Hartmann et al., 2008; Watt and Forde, 
2008). In most reports, CXCL12-abundant 
reticular cells (CARs) and osteoblasts are in-
troduced as the main sources of SDF1a in 
both osteoblastic and vascular niches (Jung 
et al., 2006; Sugiyama et al., 2006). Cyto-
kines and hormones play a role in SDF1a 
expression. For instance, TNF-α, IL-1 beta, 
PTH and PDGF-BB stimulate SDF1a secre-
tion in vitro. However, TGF-beta 1 rapidly 
reduces SDF1a expression in most osteo-
blastic cell lines (Jung et al., 2006). CXCR-4 
(also identified as fusin or CD184) is the re-
ceptor for SDF1a chemokine. SDF1a/ 
CXCR4 axis plays a role in HSCs homing 
and quiescence (Moriuchi et al., 1997; Saini 
et al., 2010). Ex vivo pretreatment of HSCs 
with high dose SDF1a reduces CD34+ cells 
engraftment, but low dose SDF1a increases 
their engraftment. These diverse effects are 
likely to be mediated by various second mes-
senger systems sensitive to different concen-
trations of SDF1a (Plett et al., 2002). 
CXCR4 has a tendency to form hetero- and 
homo oligomers, and such oligomerization 
could play a role in the allosteric regulation 
of CXCR4 signaling (Wu et al., 2010). 
CXCR4 signaling is mediated through acti-
vation of G proteins, AKT, ERK and JAK-
STAT signaling pathway (Hartmann et al., 
2008; Teicher and Fricker, 2010). Obstruc-
tion of CXCR4-SDF1a axis pathway leads to 
proliferation of HSCs (Naumann et al., 
2010). In contrast, some experiments have 
reported that SDF1a enhances the repopulat-
ing potential of CD34+cells, and have sug-
gested that the function of hematopoietic 
progenitor cells (HPCs) can be satisfactorily 
regulated through specific CXCR4 signaling 
(Plett et al., 2002). In BM cells, CXCR4 reg-
ulates the homing and presentation of circu-
lating functional SDF1a; therefore, these 
cells regulate the trafficking of HSCs togeth-
er with CXCR4 positive HSCs. Immature 
HSCs express low levels of SDF1a that can 
interact with CXCR4 on stromal cells by se-
cretion of this ligand, reversing the usual 
form of interaction and activation (Dar et al., 
2006). Stem cell factor (SCF) and IL-6 en-
hance CXCR4 on the CD34+ cells and im-
prove stem cell engraftment (Peled et al., 
1999). CXCR4 knockout mice have defec-
tive B lymphopoiesis and myelopoiesis and 
die perinatally, showing intense defects in 
the hematopoietic tissue (Ma et al., 1998). 
HIF-1 plays a role in SDF1a and CXCR4 
expression, and improves the function of 
CXCR4. Drugs such as Plerixafor 
(AMD3100) that block CXCR4 or G-CSF 
which causes elastase release from neutro-
phils and SDF1a degradation lead to HSCs 
mobilization (Balabanian et al., 2008; Ra-
jagopal et al., 2010) 
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CXCR7 as a novel receptor for SDF1a 
Although CXCR4/SDF1a was thought to 
be a single axis, the interaction of SDF1a 
with CXCR4 was questioned after Burns re-
port (Burns et al., 2006). He showed that 
small molecular inhibitors of CCX451, 
CCX751 and CXCL11 compete with SDF1a 
binding to CXCR4, with human cancer cell 
lines showing a contradictory pattern of 
CXCR4 expression and SDF1a binding. Due 
this observation, he suggested a new receptor 
for SDF1a, the orphan receptor RDC-1, 
which was named CXCR7 (Burns et al., 
2006). CXCR7 (RDC-1; CXC-CK) is a sev-
en-transmembrane-spanning chemokine pro-
tein receptor (Heesen et al., 1998) with char-
acteristic structural features similar to other 
chemokine receptors (Figure 1). However, it 
is a decoy CXC chemokine receptor similar 
to Duffy Antigen of D6 (Graham, 2009). 
Decoy chemokine family is characterized by 
modification of Asp-Arg-Tyr-Leu-Ala-Ile-
Val (DRYLAIV) motif essential for G-
protein mediated responses (Haraldsen and 
Rot, 2006; Graham, 2009). CXCR7 does not 
signal through G proteins, and is an atypical 
chemokine receptor (Rajagopal et al., 2010). 
Previously, CXCR7 was wrongly thought to 
be a receptor for vasoactive intestinal peptide 
(VIP) (Heesen et al., 1998). CXCR7 is in-
volved in several biological processes, in-
cluding embryonic development (Burns et 
al., 2006), scavenging for SDF1a and 
CXCL11 (Naumann et al., 2010), promotion 
of adhesion to activated endothelial cells, 
cell survival but not cell proliferation or tu-
mor development (Naumann et al., 2010; 
Tarnowski et al., 2010; Kumar et al., 2012). 
Like CXCR4, CXCR7 is highly conserved in 
mice and humans (Heesen et al., 1998), so 
that CXCR7 -/- mice show different heart 
abnormalities and die at birth (Sierro et al., 
2007). CXCR7 binds to SDF1a and I-TAC 
(IFN-inducible T cell chemo attractant; 
CXCR11) (Balabanian et al., 2005; Burns et 
al., 2006). Like CXCR4, CXCR7 N-terminal 
domain binds to SDF1a (Veldkamp et al., 
2008). CXCR7 is expressed in activated en-
dothelial cells, tumor cell lines, early fetal 
liver cells, transforming cells (Burns et al., 
2006), migrating primordium in zebrafish 
(Dambly-Chaudiere et al., 2007), monocytes, 
human fetal heart, neuronal tissue, adult 
mouse cerebellum, mature B cells (Infantino 
et al., 2006; Thelen and Thelen, 2008), blood 
and lymphatic endothelial cells in human re-
nal allografts (Neusser et al., 2010). Never-
theless, the expression of CXCR7 on several 
cell types is controversial (Balabanian et al., 
2005; Burns et al., 2006; Kumar et al., 
2012), and it is poorly expressed on human 
and mouse T-cells and CD34+ progenitors 
(Infantino et al., 2006; Hartmann et al., 
2008; Tarnowski et al., 2010) but the expres-
sion of its mRNA has been shown in PBL 
(Shimizu et al., 2000). CXCR7 is required 
for activation of LFA-1 and VLA-4 on T-
cells and CD 34+ cells under shear flow 
(Hartmann et al., 2008) but the role of 
CXCR7 in chemotaxis and cell migration has 
been a subject of debate. Some reports have 
suggested that CXCR7 induces T-cell migra-
tion (Balabanian et al., 2005; Kumar et al., 
2012). In contrast, other experiments showed 
that CXCR7 is not involved in SDF1a/ 
CXCR4/CXCR7 mediated T-cell and CD34+ 
mobilization (Burns et al., 2006; Hartmann 
et al., 2008; Naumann et al., 2010; Tar-
nowski et al., 2010). Like CXCR4, CXCR7 
is a co-receptor for several HIV and SIV 
strains (Shimizu et al., 2000).The human 
CXCR7 gene was mapped to chromosome 2, 
closely linked to CXCR1, CXCR2, and 
CXCR4 genes (Balabanian et al., 2005; The-
len and Thelen, 2008). CXCR7 circulates be-
tween the cell and endosomal membrane in 
presence or absence of ligand, slightly re-
duced only after long term incubation with 
SDF1a and CXCL11, leading to ligand van-
ishing due to internalization. In contrast, af-
ter encounter with ligand, CXCR4 undergoes 
down regulation and ligand disappears to 
some extent. DYR sequence deletion does 
not affect the clearance of SDF1a but C-
terminal deletion inhibits SDF1a internaliza-
tion and wiping out (Naumann et al., 2010). 
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Figure 1: Schematic structure of CXCR4 and CXCR7: CXCR4 and CXCR7 are 7TMRs that share 
binding to SDF1a. CXCR7 also binds to I-TAC. “DRYLAIV” is a common motif in GPCRs modified to 
“DRYLSIT” motif essential for G-protein responses. SDF1a/CXCR7 interactions recruit Beta-arrestin 
but not G-protein. 
 
 
CXCR7 Recruitment of beta-arrestin but 
not G-protein 
Seven-transmembrane receptors (7TMRs) 
signal through G proteins and β-arrestins 
(Figure 2). The latter function as multipur-
pose adapters controlling receptor signaling, 
desensitization and trafficking. Commonly, 
there is a balance between G protein and be-
ta-arrestin-mediated pathways. Researches 
revealed that CXCR7 does not couple to G 
proteins and cannot lead to GTP hydrolysis 
or calcium mobilization; nevertheless, it does 
trigger MAP kinases cascade through beta-
arrestins (Rajagopal et al., 2010). CXCR7 
inhibition does not affect the degree or kinet-
ics of CXCL12-triggered Akt or ERK1/2 
phosphorylation. However, one study sho-
wed that CXCR7-SDF1a interaction active-
tes ERK protein and AKT in T-cells, which 
is Giα independent (Kumar et al., 2012). In 
contrast, ERK and Akt activation is com-
pletely dependent upon CXCR4-triggered Gi 
signaling due to complete inhibition of it by 
AMD3100 and Gi- inhibitor PTX. Similar to 
other chemokines, ligand binding to CXCR7 
regulates downstream signaling pathways. 
Unlike other chemokines, decoy receptor 
CXCR7 fails to activate G-proteins respons-
es but it activates beta-arrestin pathway. Up-
on binding CXCR7, CXCL12 activates beta-
arrestin2 and mediates pERK formation, 
which is activated by G-protein. β-arrestin 
depletion reduces the migration of rVSMC in 
response to I-TAC (Rajagopal et al., 2010). 
On the other hand, a research showed 
that co-expression of CXCR4 and CXCR7 in 
the same cell leads to strong SDF1a-induced 
intracellular calcium signaling. If CXCR7 
sequesters arrestin2 away from CXCR4, this 
may eliminate signal-regulating attributes of 
the beta-arrestins, and allow for improved 
signaling through CXCR4 (Zabel et al., 
2009). It has been revealed that CXCR7 co-
operates with beta-arrestin in a ligand and 
dose independent mode, which leads to lig-
and internalization. CXCR7 recruitment of 
beta-arrestin is associated with ERK phos-
phorylation in a short period of time, which 
is then distributed in cytoplasmic vesicles in 
comparison with G protein-mediated activa-
tion of pERK, which takes longer time and is 
dispensed to cytoplasm and nucleus (Ra-
jagopal et al., 2010). Recruitment of beta-
arrestin is dependent upon C-terminal end of 
the receptor. SDF1a initiates beta-arrestin2 
association with both CXCR4 and CXCR7.  
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Figure 2: CXCR7, CXCR4 and CXCR7/CXCR4 hetrodimerization signaling pathways 
 
 
Beta-arrestin2 may create a distinct intra-
cellular signaling pathway that can partici-
pate in cross-talk between CXCR7 and 
CXCR4.  
Heterodimerization of CXCR7 with 
CXCR4 changes the comparatively different 
orientation between CXCR4 and Giα, de-
creasing SDF1a mediated G protein activa-
tion.CXCR7 has an interaction with inactive 
G protein Gai1; nevertheless, cross-regula-
tion of CXCR4 via G protein sequestration 
by CXCR7 has not been confirmed (Zabel et 
al., 2009). 7TMRs include two groups: A 
and B receptors based on communication 
with beta-arrestin molecules (Moore et al., 
2007). Class A7TMRs have a temporary in-
teraction with beta-arrestin and recycle 
quickly to the cell membrane from early en-
dosomes, binding beta-arrestin2 versus beta-
arrestin1 with high affinity. Class B 7TMRs 
show inverse properties and bind to both be-
ta-arrestin 1 and 2. CXCR7 seems to have 
characteristics of both class A and class B 
7TMRs (Luker et al., 2008). It has consider-
ably higher associations with beta-arrestin 2 
similar to class A receptors, and there are 
complexes of CXCR7 and beta-arrestin2 that 
continue to increase over time as would be 
expected for a class B receptor (Chakera et 
al., 2008). Noticeably, in the absence of 
SDF1a and under baseline situations, the in-
teraction between CXCR7 and beta-arrestin2 
is higher compared to control pairs of 
CXCR7 and c-fos or FKBP12 (Cheng et al., 
2000; Chakera et al., 2008; Luker et al., 
2009). Luker et al. (2009) reported that de-
pletion of beta-arrestin in mouse embryonic 
fibroblasts reduces but does not eliminate the 
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accumulation of SDF1a, suggesting that 
CXCR7 possibly uses another distinct path-
way for uptake of SDF1a. Agents directed 
against CXCR4 such as AMD3100, which 
are used in saturating concentrations, could 
stimulate the association between CXCR7 
and beta-arrestin2 in cells expressing both 
receptors. 
 
CXCR7 Interference with SDF1a/CXCR4 
Axis responses 
CXCR7 expression in B-cells is inversely 
correlated with the activation of CXCR4 
(Levoye et al., 2009). CXCR7 cannot intrin-
sically cause the signal to be transmitted. 
CXCR7 receptors in breast tumor cell line 
MCF-7 do not cause increased cytoplasmic 
Ca2+ or cell migration in response to SDF1a 
(Burns et al., 2006), but Ca2+ mobilization 
and chemotaxis is triggered in transformed 
T-cell line expressing CXCL4/SDF1a. Alt-
hough CXCR7 is not directly involved in 
migration of HSCP (hematopoietic stem cell 
progenitors) (Tarnowski et al., 2010), its 
modulatory role in CXCR4/SDF1 axis has 
been mentioned in literature.  
CXCR7 can also act as a sink for SDF1a 
and regulates chemokine gradients (Nau-
mann et al., 2010; Hoffmann et al., 2012). 
Hartmann et al. (2008) suggested two pools 
of CXCR7 in CD34+ cells: the first ex-
pressed on cell surface and the second intra-
cellular, the localization of which is associat-
ed with early endosomes. CXCR7 induces 
SDF1a internalization and degradation 
(Naumann et al., 2010). CXCR4 heterodi-
merization with CXCR7 selectively impairs 
the ability of CXCR4 to activate G proteins 
after ligand binding, and alters CXCL12-
CXCR7 axis mediated calcium responses 
and chemotaxis of T-cells (Levoye et al., 
2009). 
 
CXCR7 response is up-regulated by VLA-4 
and LFA-1 
The retention of adult HSCs in the bone 
marrow niche is controlled by several factors 
such as adhesion receptors, including integ-
rins. Very late activation antigen-4 (VLA-4; 
α4β1) and lymphocyte function-associated 
antigen-1 (LFA-1; αLβ2) are integrin mole-
cules involved in hematopoietic cell traffick-
ing (Milner and Campbell, 2002). LFA-1 and 
VLA-4 are expressed in HSCs (Williams et 
al., 1991). Activation of LFA-1 and VLA-4 
on lymphocytes is inhibited by PTX. SDF1a- 
triggers the activation of integrin through G 
protein–coupled chemokine receptor 
CXCR4, which is inactivated by PTX 
(Hartmann et al., 2008). CXCR7 effects 
SDF1a–CXCR4-triggered activation of 
LFA-1 and VLA-4 in T-cells as well as 
CXCR4 and CXCR7 uptake, which is neces-
sary for LFA-1 and VLA-4 activation in T-
cells on TNF-α activated HUVEC (Hart-
mann et al., 2008).The majority of CXCL12-
triggered lymphocytes in inflammatory en-
dothelial tissue are inhibited by CXCR7 
blocking (Hartmann et al., 2008). Moreover, 
antagonism of CXCR7 attenuates chronic 
hypoxia–induced pulmonary vascular adhe-
sion (Sartina et al., 2012). According to these 
investigations, high expression of integrin is 
shown to be efficient for homing and reten-
tion of lymphocytes (Gorfu et al., 2009), 
macrophages (Patel et al., 1998) and HSCs 
(Watanabe et al., 1998; Fibbe et al., 2000; 
Kronenwett et al., 2000; Scott et al., 2003; 
Rettig et al., 2012). CXCR7 is required for 
integrin activation through CXCR4/SDF1a 
pathway, and CXCR7/SDF1a is a likely 
modulatory axis regulating CXCR4/SDF1a-
mediated HSCs homing. Transfected 
CXCR7 positive cells are adhered to the ac-
tivated HUVECs considerably higher than 
intact cells (Burns et al., 2006). TNFα and 
IL-1β promote de novo CXCR7 expression 
on endothelial cells (Burns et al., 2006). 
 
CONCLUSION 
SDF1a/CXCR4 axis is regulated by 
many factors (Forde et al., 2007; Williams et 
al., 2008). According to previous content, 
CXCR7 is an important modulation factor. 
CXCR7 binds I-TAC and SDF1a, both of 
which can compete for binding to it. Howev-
er, CXCR4 is a specific receptor for SDF1a 
(Burns et al., 2006). I-TAC/CXCR7-medai-
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ted responses may interfere and compete 
with CXCR7-SDF1a mediated interaction 
(Burns et al., 2006). CXCR4 expression is 
observed on HSCs and other cells. In con-
trast to CXCR4, CXCR7 is expressed on 
embryonic HSCs and cancer transformed 
cells. There is evidence that primitive eryth-
rocytes express CXCR7 (Berahovich et al., 
2010) and traffic in embryonic CXCR7+ liv-
er cells at E11-E13 in response to SDF1a 
(Burns et al., 2006), so CXCR7 is likely to 
play a role in processes regulated by SDF1a. 
CXCR7 expression is up-regulated in some 
hematopoietic neoplasms like human B lym-
phoma (Burns et al., 2006). CXCR7 block-
ing by antibody reduces the arrest of HSCs 
on immobilized VCAM-1 (Hartmann et al., 
2008). Zebra fish lateral-line primordium mi-
gration can be mediated only via CXCR7 
(Valentin et al., 2007). In addition, CXCR4 
and CXCR7 are able to form heterodimer 
and homodimers and regulate CXCL12-pro-
moted homing of HSCs (Levoye et al., 
2009). Some observations have demonstrat-
ed miRNA-mediated post translational regu-
lation with CXCR7 and SDF1a expression 
(Staton et al., 2011). Mutation in Von Hip-
pel-Lindau (VHL), which degrades HIF1, 
leads to overexpression of CXCR4 (Burger 
and Kipps, 2006). CXCR7 promoter contains 
two hypoxia-responsive elements (Tarnows-
ki et al., 2010). CXCR7 expression is up-
regulated by hypoxia in human microvascu-
lar endothelial cells (Schutyser et al., 2007; 
Esencay et al., 2013). Overall, CXCR7/ 
SDF1a axis suggested a new migration path 
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